216 related articles for article (PubMed ID: 35397311)
1. Skeletal muscle is prognostic in resected stage III malignant melanoma.
Youn S; Eurich DT; McCall M; Walker J; Smylie M; Sawyer MB
Clin Nutr; 2022 May; 41(5):1066-1072. PubMed ID: 35397311
[TBL] [Abstract][Full Text] [Related]
2. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
[TBL] [Abstract][Full Text] [Related]
3. Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study.
Cortellini A; Bozzetti F; Palumbo P; Brocco D; Di Marino P; Tinari N; De Tursi M; Agostinelli V; Patruno L; Valdesi C; Mereu M; Verna L; Lanfiuti Baldi P; Venditti O; Cannita K; Masciocchi C; Barile A; McQuade JL; Ficorella C; Porzio G
Sci Rep; 2020 Jan; 10(1):1456. PubMed ID: 31996766
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia as a Predictor of Survival in Patients with Pancreatic Adenocarcinoma After Pancreatectomy.
Rom H; Tamir S; Van Vugt JLA; Berger Y; Perl G; Morgenstern S; Tovar A; Brenner B; Benchimol D; Kashtan H; Sadot E
Ann Surg Oncol; 2022 Mar; 29(3):1553-1563. PubMed ID: 34716836
[TBL] [Abstract][Full Text] [Related]
5. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
[TBL] [Abstract][Full Text] [Related]
6. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
Findlay M; White K; Brown C; Bauer JD
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
[TBL] [Abstract][Full Text] [Related]
8. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
9. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
[TBL] [Abstract][Full Text] [Related]
10. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
[TBL] [Abstract][Full Text] [Related]
11. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT).
Chan DL; Clarke SJ; Engel A; Diakos CI; Pavlakis N; Roach PJ; Bailey DL; Bauer J; Findlay M
Eur J Clin Nutr; 2022 Jan; 76(1):143-149. PubMed ID: 33986486
[TBL] [Abstract][Full Text] [Related]
13. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
Shirdel M; Andersson F; Myte R; Axelsson J; Rutegård M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
[No Abstract] [Full Text] [Related]
14. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
[TBL] [Abstract][Full Text] [Related]
15. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer.
Park IK; Yang SS; Chung E; Cho ES; Lee HS; Shin SJ; Im YC; Park EJ; Baik SH; Lee KY; Kang J
Cancer Med; 2021 Dec; 10(23):8451-8461. PubMed ID: 34643052
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
Kim DW; Ahn H; Kim KW; Lee SS; Kim HJ; Ko Y; Park T; Lee J
Korean J Radiol; 2022 Nov; 23(11):1055-1066. PubMed ID: 36098341
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study.
Maurits JSF; Sedelaar JPM; Mulders PFA; Aben KKH; Kiemeney LALM; Vrieling A
Clin Nutr; 2022 Jan; 41(1):131-143. PubMed ID: 34872047
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer.
Kim M; Lee SM; Son IT; Park T; Oh BY
Korean J Radiol; 2023 Sep; 24(9):849-859. PubMed ID: 37634640
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
